$128.60
1.72[1.36%]
At close: Apr 30
$128.60
0[0.00%]
After Hours: 7:58PM EDT
Novo Nordisk
(NYSE:NVO)Latest News for Novo Nordisk Stock (NYSE:NVO)
Novo Nordisk Stock (NYSE: NVO)
Categories: All
Monday, April 29, 2024
- Decoding Novo Nordisk's Options Activity: What's the Big Picture?Benzinga Insights - 1 day ago
- FDA Says Novo Nordisk's Wegovy, Injection, 1.7 mg/.75 ml (NDC 0169-4517-14) Is AvailableBenzinga Newsdesk - 1 day ago
- FDA Says Novo's Wegovy, Injection, .25 mg/.5 ml (NDC 0169-4525-14) Under Limited Availability With Estimated Shortage Duration TBD; Wegovy, Injection, .5 mg/.5 ml (NDC 0169-4505-14) Under Limited Availability With Estimated Shortage Duration TBD; Wegovy, Injection, 1 mg/.5 ml (NDC 0169-4501-14) Limited Availability With Estimated Shortage Duration TBDBenzinga Newsdesk - 1 day ago
Friday, April 26, 2024
Wednesday, April 24, 2024
- What Are Pricing Strategies for Ozempic And Wegovy With Potential Medicare Coverage Expansion? Senate Committee Questions Novo NordiskVandana Singh - 6 days ago
- "Senate Committee Investigates Ozempic And Wegovy Costs; Senator Bernie Sanders Is Pressing The Drugmaker Novo Nordisk For Details On Its Pricing Of The Popular Diabetes And Weight Loss Medications" - NY TimesBenzinga Newsdesk - 6 days ago
Monday, April 22, 2024
Thursday, April 18, 2024
- German Authority Gives Go Ahead To Novo Nordisk's Small Bolt On Acquisition As Danish Firm Seeks To Build Heart Drugs PipelineVandana Singh - Apr 18, 2024, 1:55PM
- Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025Vandana Singh - Apr 18, 2024, 12:50PM
- Cantor Fitzgerald Reiterates Overweight on Novo Nordisk, Maintains $160 Price TargetBenzinga Newsdesk - Apr 18, 2024, 9:59AM
Wednesday, April 17, 2024
Monday, April 15, 2024
Friday, April 12, 2024
- Novo Nordisk's Dominance In Obesity & Diabetes Drug Market Backed by Strong Pipeline: Analyst Gives Outperform RatingVandana Singh - Apr 12, 2024, 1:22PM
- Eli Lilly Suffers Legal Loss For Its Popular Weight Loss/Diabetes Drug In Lawsuit Against Florida Compounding PharmacyVandana Singh - Apr 12, 2024, 11:54AM
- Novo Nordisk/Eli Lilly's Weight Loss Drugs Does Not Cause Suicidal Behaviors - After FDA, European Medicines Agency SaysVandana Singh - Apr 12, 2024, 10:40AM
- Novo Nordisk shares are trading higher after EU regulators reportedly ruled out a link between wight loss drugs and suicidal thoughts. Additionally, BMO Capital initiated coverage on the stock with an Outperform rating.Benzinga Newsdesk - Apr 12, 2024, 9:37AM
- Pharmacovigilance Risk Assessment Committee Clears GLP-1 Diabetes Medications of Causing Suicidal or Self-Injurious BehaviorBenzinga Newsdesk - Apr 12, 2024, 8:02AM
- BMO Capital Initiates Coverage On Novo Nordisk with Outperform Rating, Announces Price Target of $163Benzinga Newsdesk - Apr 12, 2024, 5:15AM
Thursday, April 11, 2024
Wednesday, April 10, 2024
Tuesday, April 09, 2024
- Shares of Lilly and Novo Nordisk are trading lower on reports suggesting the EMA this will meet to discuss the possible link between GLP-1 drugs and suicidal thoughts. Stocks across sectors are also lower ahead of Wednesday inflation data.Benzinga Newsdesk - Apr 9, 2024, 1:34PM
- Check Out What Whales Are Doing With NVOBenzinga Insights - Apr 9, 2024, 12:15PM
Friday, April 05, 2024
Wednesday, April 03, 2024
- Eli Lilly Struggles To Keep Pace With Mounjaro, Zepbound Demand: 'Currently Unavailable' On Amazon PharmacyNeil Dennis - Apr 3, 2024, 4:07PM
- Novo Nordisk's Popular Diabetes Drug Ozempic Starter Kits Face Extended Shortages in Germany, Faces Biosimilar Threat In ChinaVandana Singh - Apr 3, 2024, 1:37PM
- Costco Long Known For Rotisserie Chicken And Hot Dogs Counters Junk Food With Weight Loss Plan To Help You Shed Those ExtrasBenzinga Neuro - Apr 3, 2024, 3:21AM
Tuesday, April 02, 2024
- AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss RaceVandana Singh - Apr 2, 2024, 2:54PM
- Citi Monitors Competitive Threats To Eli Lilly, Says It Is Positioned To Maintain Leadership And ExpandVandana Singh - Apr 2, 2024, 2:41PM
- Eli Lilly Stock Navigates Weight-Loss Drug Competition With Technical ResilienceSurbhi Jain - Apr 2, 2024, 11:39AM
- Smart Money Is Betting Big In NVO OptionsBenzinga Insights - Apr 2, 2024, 11:16AM
- Diabetes Drug Made For Under $5 Costs Americans $1,000, Drawing Comparisons To Martin Shkreli While Juicing Profits for A Drug GiantCaleb Naysmith - Apr 2, 2024, 11:00AM
Monday, April 01, 2024
Saturday, March 30, 2024
Friday, March 29, 2024
Thursday, March 28, 2024
- Scholar Rock Is A Potential M&A Target, Its Exploration of Obesity Market Garners Interest: AnalystVandana Singh - Mar 28, 2024, 2:42PM
- 10 Health Care Stocks With Whale Alerts In Today's SessionBenzinga Insights - Mar 28, 2024, 1:35PM
- How Much Does It Cost To Make Novo Nordisk's Ozempic? Shockingly Low Against $1,000 Price Tag, Study ShowsVandana Singh - Mar 28, 2024, 12:54PM
- Novo Nordisk shares are trading higher after some US insurers extended coverage of Wegovy to include certain people on Medicare with heart-related conditions.Benzinga Newsdesk - Mar 28, 2024, 10:54AM
- Elevance, CVS Health Are First Medicare Insurers To Cover Novo Nordisk's Weight Loss Sensation WegovyVandana Singh - Mar 28, 2024, 10:25AM
- What the Options Market Tells Us About Novo NordiskBenzinga Insights - Mar 28, 2024, 10:01AM
- "First Medicare Health Plans To Start Paying For Weight-Loss Drugs; CVS, Elevance, Kaiser Permanente Medicare Plans To Cover Wegovy To Cut Heart Risk; Use Of Wegovy, Other Obesity Drugs For Weight Loss Alone Still Excluded From Medicare" - WSJBenzinga Newsdesk - Mar 28, 2024, 9:11AM
Wednesday, March 27, 2024
Tuesday, March 26, 2024
- Krispy Kreme-McDonald's Deal Spikes Insulin Stock Interest: 'We're About To Cash In On The Aftermath'Surbhi Jain - Mar 26, 2024, 3:19PM
- Obesity Drug Landscape Has A Contender From Biohaven, CEO Highlights Different Approach Amid Stiff Competition From Novo Nordisk, Eli LillyVandana Singh - Mar 26, 2024, 1:48PM
- Here's How Much $1000 Invested In Novo Nordisk 10 Years Ago Would Be Worth TodayBenzinga Insights - Mar 26, 2024, 12:00PM
Monday, March 25, 2024
- Looking At Novo Nordisk's Recent Unusual Options ActivityBenzinga Insights - Mar 25, 2024, 3:16PM
- Cramer Isn't 'Knocking' This Pharma Firm Anymore: 'As A Matter Of Fact, I'm Going In'Avi Kapoor - Mar 25, 2024, 9:05AM
- Actylis And Novo Nordisk Pharmatech Have Agreed To Distribute Pharmaceutical Grade Benzalkonium Chloride To The Pharmaceutical And Medical Device Markets In Germany, Spain, Portugal, The UK And IrelandBenzinga Newsdesk - Mar 25, 2024, 7:40AM